Vol. 4 No. 1 (2024): January−June 2024
Articles

Deep Learning-Based Early Warning Model for Continuous Glucose Monitoring Data in Diabetes Management

Meizhizi Jin
Management Information Systems, New York University, NY, USA
Haodong Zhang
Computer Science, New York University, NY, USA
Decheng Huang
Chemical and Biomolecular Engineering, University of Pennsylvania, Philadelphia, PA, USA

Published 2024-02-26

Keywords

  • Continuous Glucose Monitoring,
  • Deep Learning,
  • Early Warning System,
  • Diabetes Management

How to Cite

Jin, M., Zhang, H., & Huang, D. (2024). Deep Learning-Based Early Warning Model for Continuous Glucose Monitoring Data in Diabetes Management . Spectrum of Research, 4(1). Retrieved from https://spectrumofresearch.com/index.php/sr/article/view/4

Abstract

This paper presents a novel deep learning-based early warning system for blood glucose prediction utilizing continuous glucose monitoring (CGM) data. The proposed system combines advanced temporal fusion transformer architecture with multi-head attention mechanisms to provide accurate glucose predictions and timely alerts for potential glycemic events. The model was evaluated on two comprehensive datasets: OhioT1DM and ShanghaiDM, encompassing 124 subjects with type 1 and type 2 diabetes. The system achieved superior prediction accuracy with RMSE values of 13.7 ± 1.5 mg/dL and 15.4 ± 1.8 mg/dL for 30 and 60-minute horizons, respectively, outperforming traditional machine learning approaches. The implementation of population-specific characteristics and attention mechanisms enhanced the model's ability to capture complex temporal dependencies in glucose dynamics while maintaining robust performance across diverse patient populations. Clinical validation demonstrated a 45% reduction in severe glycemic events and 32% improvement in glycemic variability metrics. The early warning system reduced response time to critical events by 58% compared to conventional monitoring methods. The system's integration of deep learning with CGM technology represents a significant advancement in personalized diabetes management, offering potential for improved patient outcomes through preemptive intervention strategies.